Bionano Genomics Inc (BNGO)
0.95
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.945
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Cash from Financing (TTM): 113.82M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 113.82M |
September 30, 2023 | 45.48M |
June 30, 2023 | 55.54M |
March 31, 2023 | 37.86M |
December 31, 2022 | 23.01M |
September 30, 2022 | 24.83M |
June 30, 2022 | 15.94M |
March 31, 2022 | -1.418M |
December 31, 2021 | 336.11M |
September 30, 2021 | 365.83M |
June 30, 2021 | 367.15M |
March 31, 2021 | 400.57M |
December 31, 2020 | 61.90M |
Date | Value |
---|---|
September 30, 2020 | 48.71M |
June 30, 2020 | 33.84M |
March 31, 2020 | 18.39M |
December 31, 2019 | 30.38M |
September 30, 2019 | 11.86M |
June 30, 2019 | 30.90M |
March 31, 2019 | 33.31M |
December 31, 2018 | 35.78M |
September 30, 2018 | 37.28M |
June 30, 2018 | 20.92M |
March 31, 2018 | 23.96M |
December 31, 2017 | 17.61M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.418M
Minimum
Mar 2022
400.57M
Maximum
Mar 2021
106.35M
Average
37.86M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
Bruker Corp | -11.00M |
Azenta Inc | -452.51M |
Harvard Bioscience Inc | -12.13M |
Akoya Biosciences Inc | 56.84M |
Singular Genomics Systems Inc | 0.696M |